Minocycline does not affect amyloid β phagocytosis by human microglial cells

Neuroscience Letters

Volumn 416, Issue 1, 2007, Pages 87-91

  Familian, Atoosa ^a   Eikelenboom, Piet ^a,c   Veerhuis, Robert ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Amyloid ; C1q; Microglia; Minocycline; Phagocytosis; SAP

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; COMPLEMENT COMPONENT C1Q; CYTOKINE; MINOCYCLINE; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; MICROGLIA; NEUROPROTECTION; PHAGOCYTOSIS; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; ANTI-BACTERIAL AGENTS; COMPLEMENT C1Q; CYTOKINES; DOWN-REGULATION; HUMANS; MICROGLIA; MINOCYCLINE; PEPTIDE FRAGMENTS; PHAGOCYTOSIS; SERUM AMYLOID P-COMPONENT;

EID: 33947281600     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.01.052     Document Type: Article

References (27)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
2. Ard M.D., Cole G.M., Wei J., Mehrle A.P., and Fratkin J.D. Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J. Neurosci. Res. 43 (1996) 190-202
3. Arends Y.M., Duyckaerts C., Rozemuller J.M., Eikelenboom P., and Hauw J.J. Microglia, amyloid and dementia in alzheimer disease. A correlative study. Neurobiol. Aging 21 (2000) 39-47
4. D'Andrea M.R., Cole G.M., and Ard M.D. The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol. Aging 25 (2004) 675-683
5. De Groot C.J., Montagne L., Janssen I., Ravid R., van der Valk P., and Veerhuis R. Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue. Brain Res. Brain Res. Protoc. 5 (2000) 85-94
6. Domercq M., and Matute C. Neuroprotection by tetracyclines. Trends Pharmacol. Sci. 25 (2004) 609-612
7. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., and Loike J.D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382 (1996) 716-719
8. Familian A., Boshuizen R.S., Eikelenboom P., and Veerhuis R. Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation. Glia 53 (2006) 233-240
9. Forloni G., Colombo L., Girola L., Tagliavini F., and Salmona M. Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett. 487 (2001) 404-407
10. Gordon P.H., Moore D.H., Gelinas D.F., Qualls C., Meister M.E., Werner J., Mendoza M., Mass J., Kushner G., and Miller R.G. Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology 62 (2004) 1845-1847
11. Griffin W.S. Inflammation and neurodegenerative diseases. Am. J. Clin. Nutr. 83 (2006) 470S-474S
12. Honda M., Akiyama H., Yamada Y., Kondo H., Kawabe Y., Takeya M., Takahashi K., Suzuki H., Doi T., Sakamoto A., Ookawara S., Mato M., Gough P.J., Greaves D.R., Gordon S., Kodama T., and Matsushita M. Immunohistochemical evidence for a macrophage scavenger receptor in Mato cells and reactive microglia of ischemia and Alzheimer's disease. Biochem. Biophys. Res. Commun. 245 (1998) 734-740
13. Lai A.Y., and Todd K.G. Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines. Glia 53 (2006) 809-816
14. Metz L.M., Zhang Y., Yeung M., Patry D.G., Bell R.B., Stoian C.A., Yong V.W., Patten S.B., Duquette P., Antel J.P., and Mitchell J.R. Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann. Neurol. 55 (2004) 756
15. Rogers J., Strohmeyer R., Kovelowski C.J., and Li R. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40 (2002) 260-269
16. Seabrook T.J., Jiang L., Maier M., and Lemere C.A. Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice. Glia 53 (2006) 776-782
17. Stirling D.P., Koochesfahani K.M., Steeves J.D., and Tetzlaff W. Minocycline as a neuroprotective agent. Neuroscientist 11 (2005) 308-322
18. Strohmeyer R., Kovelowski C.J., Mastroeni D., Leonard B., Grover A., and Rogers J. Microglial responses to amyloid beta peptide opsonization and indomethacin treatment. J. Neuroinflamm. 2 (2005) 18
19. Thomas M., Ashizawa T., and Jankovic J. Minocycline in Huntington's disease: a pilot study. Mov. Disord. 19 (2004) 692-695
20. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., and Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21 (2001) 2580-2588
21. Tuppo E.E., and Arias H.R. The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell Biol. 37 (2005) 289-305
22. Veerhuis R., Boshuizen R.S., and Familian A. Amyloid associated proteins in Alzheimer's and prion disease. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 235-248
23. Veerhuis R., Van Breemen M.J., Hoozemans J.M., Morbin M., Ouladhadj J., Tagliavini F., and Eikelenboom P. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro. Acta Neuropathol. (Berl) 105 (2003) 135-144
24. Webster S.D., Yang A.J., Margol L., Garzon-Rodriguez W., Glabe C.G., and Tenner A.J. Complement component C1q modulates the phagocytosis of Abeta by microglia. Exp. Neurol. 161 (2000) 127-138
25. Wegiel J., Wang K.C., Tarnawski M., and Lach B. Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation. Acta Neuropathol. (Berl) 100 (2000) 356-364
26. Weldon D.T., Rogers S.D., Ghilardi J.R., Finke M.P., Cleary J.P., O'Hare E., Esler W.P., Maggio J.E., and Mantyh P.W. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 18 (1998) 2161-2173
27. Yrjänheikki J., Tikka T., Keinänen R., Goldsteins G., Chan P.H., and Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13496-13500